LED Medical Diagnostics Announces Delay in Reporting Audited Year-End Results

LED Medical Diagnostics Inc. (TSX VENTURE:LMD)(OTCQX:LEDIF)(FRANKFURT:LME)
("LED" or the "Company") today announced that it will not be in a position to
file its audited financial statements, management's discussions and analysis and
related certifications for the fiscal year ended December 31, 2012, on or before
April 30, 2013, as required, due to the determination in consultation with its
new auditor that LED must revise its previously reported financial statement
information. The restatement is due to a change in the Company's functional and
reporting currency to United States dollars from Canadian dollars and a revision
to LED's prior revenue recognition policy pertaining to the sales of its product
in fiscal 2011 and 2012 to its then exclusive distributor, Henry Schein Inc.,
from "sell to the distributor" to "sell through this distributor to their end
customers". The revision to LED's revenue recognition policy was brought to the
Company's attention in April 2013 and LED has since been reviewing and
discussing this issue with its new auditor and its former auditor. The change in
functional and reporting currency and revision in revenue recognition policy
have created a significant amount of additional work to be performed by LED to
complete the audited statements. LED has been working closely with its auditor
and expects to be able to have the audit of the financial statements completed,
and the statements filed, by May 3, 2013.


LED confirms that it intends to satisfy the alternative information guidelines
of Section 4.4 of National Policy 12-203 including the issuance of biweekly
default status reports for so long as LED remains in default of the financial
statement filing requirement.


The Audit Committee of the Company has reviewed the contents of this news release.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED
Medical Diagnostics Inc. is a leading developer of LED-based visualization
technologies for the medical industry. The Company is currently listed on the
Toronto Stock Exchange (TSX-V) under the symbol "LMD", the OTCQX under the
symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME".
For more information, visit www.ledmd.com. Through its wholly-owned subsidiary,
LED Dental Inc., the company manufactures the VELscope(R) Vx Enhanced Oral
Assessment System, the first system in the world to apply tissue fluorescence
visualization technology to the oral cavity. VELscope(R) Vx devices are now used
to conduct more screenings for oral cancer and other oral tissue abnormalities
than any other adjunctive device. For more information, visit www.leddental.com.


FOR FURTHER INFORMATION PLEASE CONTACT: 
LED Medical Diagnostics Inc.
Mark Komonoski, Investor Relations
[phone] or Toll-Free: [phone]
Cell: [phone]
[e-mail]
Skype: mkomonoski